Tina Hieken

Professor of Surgery

Mayo Clinic Minnesota

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Tina Hieken is a Professor of Surgery at the Mayo Clinic in Rochester, Minnesota. Her research focuses on cancer surgery and treatment, particularly in the areas of breast cancer and melanoma. Recent articles authored by Dr. Hieken explore the efficacy of neoadjuvant therapies and compliance with cancer care standards.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Collaborators (4)

Jane Yuet Ching Hui

University of Minnesota

UNITED STATES

View details

Mary Mrdutt

Assistant Professor

Mayo Clinic

UNITED STATES

View details

Evidio Domingo-Musibay

Assistant Professor of Medicine

University of Minnesota Medical Center

UNITED STATES

View details

Alexander Christopher Jonathan van Akkooi

Associate Professor

Melanoma Institute Australia

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tina Hieken

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Early Compliance with Commission on Cancer Operative Standards for Breast Cancer Surgery

Does RECIST 1.1 Predict Nodal Response to Neoadjuvant Chemo‐Immunotherapy in Breast Cancer?

NeoACTIVATE Arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable Stage III melanoma

Baseline Compliance with Commission on Cancer Standard 5.5: Wide Local Excision for Primary Cutaneous Melanoma

ASO Author Reflections: Improving the Quality of Cancer Care: Surgical Standards Version 1.0

ASO Visual Abstract: Early Compliance with Commission on Cancer Operative Standards for Breast Cancer Surgery

A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first‐line treatment for patients with melanoma in‐transit metastases

Setting the Standard for the Future of Cancer Surgery: Utilizing the Operative Standards for Trainees

Correlation of PET-CT Nodal Imaging and Pathologic Response to Neoadjuvant Immunotherapy for Node-Positive Breast Cancer

Advances from targeted therapy for non‐metastatic HER2‐positive inflammatory breast cancer

Collaborators (4)

Jane Yuet Ching Hui

Mary Mrdutt

Evidio Domingo-Musibay

Alexander Christopher Jonathan van Akkooi

Make your next move.